Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is supported by educational grants from AstraZeneca, Celgene Corporation, and Merck Sharp & Dohme Corp.
Release Date: July 31, 2018
Expiration Date: July 31, 2019
Media: Internet - based
Instructions for This Activity and Receiving Credit
Upon successful completion of this educational program, participants should be better prepared to:
Faculty, Staff, and Planners' Disclosure
Joyce O'Shaughnessy, MD
Celebrating Women Chair in Breast Cancer Research
Baylor Charles A. Sammons Cancer Center
Co-Chair, Breast Cancer Research Program
The US Oncology Network
Disclosure: Consultant: AstraZeneca, Novartis, Lilly; Speakers Bureau: AstraZeneca, Lilly
Tiffany A. Traina, MD
Clinical Director, Breast Medicine Service
Section Head, Triple Negative Breast Cancer Clinical Research Program
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College
New York, NY
Disclosure: Consultant: Genentech/Roche, Eisai, Medivation, Pfizer, AstraZeneca, Merck, Astellas Pharma, Puma Biotechnology, Advaxis, Celgene, Innocrin Pharma, Genomic Health, Bristol-Myers Squibb, Samsung; Speakers Bureau: Roche/Genentech; Research Funding: Medivation, Eisai, Pfizer, Novartis, Innocrin Pharma, AstraZeneca, Astellas Pharma
Charles Shapiro, MD
Professor of Medicine
Director, Translational Breast Cancer Research
Icahn School of Medicine at Mount Sinai
New York, NY
Disclosure: Dr. Charles Shapiro has no relevant financial relationships with commercial interests to disclose.
Jenny Chang, MD
Director, Methodist Cancer Center
The Methodist Hospital
Disclosure: Dr. Jenny Chang has no relevant financial relationships with commercial interests to disclose.
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with commercial interests to disclose.
As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.
Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.
This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician or nurse relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®.
Cancer Summaries and Commentaries™: Update from Atlanta – Advances in the Treatment of Multiple Myeloma
Feb 28, 2019
Feb 28, 2019
Feb 28, 2019
23rd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma
February 28, 2019 - March 3, 2019